Skip to content
646 269 0773|alita@globalbioethics.org
facebooktwitterlinkedin
Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo
  • Home
  • About
  • Staff
    • Founders
    • Board of Directors
    • Advisory Board
    • Visiting Scholars
    • Student Interns
    • Volunteers
  • Events
  • Resources
    • COVID-19
  • Internships
  • Contact
  • Donate
Previous Next
  • View Larger Image

Texas Governor Abbott Authorizes Use of Experimental Stem Cell Therapies

The government of Texas has passed a bill permitting clinics statewide to use experimental stem cell therapies on select chronically and terminally ill patients. Signed by Governor Greg Abbott, the legislation is akin to the “right to try” laws that have emerged in other states, and sidesteps FDA regulations that prohibit the marketing of unapproved therapies. A possible alternative to approved treatment methods, the law particularly signals hope for patients for whom traditional options are failing or unviable.

Stem cell treatments involve the extraction of stem cells from adult tissues and their subsequent therapeutic use on patients. Under the new law, the treatment method must be prescribed and administered by a physician, delivered at a hospital or medical center, and overseen by an institutional review board (IRB). Only therapies that have already been tested in human clinical trials are affected by the bill’s expansive permissions.

The contentious legislation has been celebrated by some patient advocates, but condemned by certain leading bioethicists, among them University of Minnesota’s Leigh Turner and NYU Langone Medical Center’s Beth Roxland. In Science, Turner expressed concern about monitoring practices over clinics, while Roxland warned that clinical trials are inadequate tests in the absence of FDA approval.

Though Turner noted the “powerful symbolic value” in “setting up this conflict between state law and federal law,” he felt that “it would really be surprising if anybody in Texas is going to wander around the state making sure that businesses are complying with these standards.” Roxland remarked, “You could gain access to something [as long as it’s] being studied in a human… somewhere on the planet, which in the stem cell area makes it really very scary.”

By Ana Lita|2017-07-10T20:46:51+00:00July 10th, 2017|News-Articles|0 Comments

Share This Story, Choose Your Platform!

facebooktwitterlinkedinreddittumblrpinterestvkEmail

About the Author: Ana Lita

Ana Lita

Related Posts

  • Prof Cheah Phaik Yeong
    Prof Cheah Phaik Yeong
    Gallery

    Prof Cheah Phaik Yeong

  • 2022 “Bioethics, Wars and Pandemics” Testimonials
    2022 “Bioethics, Wars and Pandemics” Testimonials
    Gallery

    2022 “Bioethics, Wars and Pandemics” Testimonials

  • Bioethics in the Second Cold War by Jonathan D Moreno PhD
    Bioethics in the Second Cold War by Jonathan D Moreno PhD
    Gallery

    Bioethics in the Second Cold War by Jonathan D Moreno PhD

  • Call for Applications: “Bioethics, Wars and Pandemics” Summer School Online (July 18 – 23) 2022
    Call for Applications: “Bioethics, Wars and Pandemics” Summer School Online (July 18 – 23) 2022
    Gallery

    Call for Applications: “Bioethics, Wars and Pandemics” Summer School Online (July 18 – 23) 2022

  • Mariupol Maternity Hospital Third To Be Destroyed In Ukraine: UN
    Mariupol Maternity Hospital Third To Be Destroyed In Ukraine: UN
    Gallery

    Mariupol Maternity Hospital Third To Be Destroyed In Ukraine: UN

Leave A Comment Cancel reply

Recent Tweets

Tweets by GBISummerSchool

Find us on Facebook

Copyright 2012 - 2020 Global Bioethics | All Rights Reserved | Powered by Global Innovation Consortium
facebooktwitterlinkedin
Toggle Sliding Bar Area